Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 48: 1296-1304, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (383)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, J.
Right arrow Articles by Chan, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, J.
Right arrow Articles by Chan, D. W.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Cancer Diagnostics (since 2002)
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2002;48:1296-1304.)
© 2002 American Association for Clinical Chemistry, Inc.

Proteomics and Bioinformatics Approaches for Identification of Serum Biomarkers to Detect Breast Cancer

Jinong Li1, Zhen Zhang1, Jason Rosenzweig1, Young Y. Wang1 and Daniel W. Chana1

1 Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21287.

aAuthor for correspondence.

Background: Surface-enhanced laser desorption/ionization (SELDI) is an affinity-based mass spectrometric method in which proteins of interest are selectively adsorbed to a chemically modified surface on a biochip, whereas impurities are removed by washing with buffer. This technology allows sensitive and high-throughput protein profiling of complex biological specimens.

Methods: We screened for potential tumor biomarkers in 169 serum samples, including samples from a cancer group of 103 breast cancer patients at different clinical stages [stage 0 (n = 4), stage I (n = 38), stage II (n = 37), and stage III (n = 24)], from a control group of 41 healthy women, and from 25 patients with benign breast diseases. Diluted serum samples were applied to immobilized metal affinity capture Ciphergen ProteinChip® Arrays previously activated with Ni2+. Proteins bound to the chelated metal were analyzed on a ProteinChip Reader Model PBS II. Complex protein profiles of different diagnostic groups were compared and analyzed using the ProPeak software package.

Results: A panel of three biomarkers was selected based on their collective contribution to the optimal separation between stage 0–I breast cancer patients and noncancer controls. The same separation was observed using independent test data from stage II–III breast cancer patients. Bootstrap cross-validation demonstrated that a sensitivity of 93% for all cancer patients and a specificity of 91% for all controls were achieved by a composite index derived by multivariate logistic regression using the three selected biomarkers.

Conclusions: Proteomics approaches such as SELDI mass spectrometry, in conjunction with bioinformatics tools, could greatly facilitate the discovery of new and better biomarkers. The high sensitivity and specificity achieved by the combined use of the selected biomarkers show great potential for the early detection of breast cancer.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
D. McLerran, W. E. Grizzle, Z. Feng, W. L. Bigbee, L. L. Banez, L. H. Cazares, D. W. Chan, J. Diaz, E. Izbicka, J. Kagan, et al.
Analytical Validation of Serum Proteomic Profiling for Diagnosis of Prostate Cancer: Sources of Sample Bias
Clin. Chem., January 1, 2008; 54(1): 44 - 52.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
L. Harris, H. Fritsche, R. Mennel, L. Norton, P. Ravdin, S. Taube, M. R. Somerfield, D. F. Hayes, and R. C. Bast Jr
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
J. Clin. Oncol., November 20, 2007; 25(33): 5287 - 5312.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
H. Zhang and D. W. Chan
Cancer Biomarker Discovery in Plasma Using a Tissue-targeted Proteomic Approach
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1915 - 1917.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
C. Belluco, E. F. Petricoin, E. Mammano, F. Facchiano, S. Ross-Rucker, D. Nitti, C. Di Maggio, C. Liu, M. Lise, L. A. Liotta, et al.
Serum Proteomic Analysis Identifies a Highly Sensitive and Specific Discriminatory Pattern in Stage 1 Breast Cancer
Ann. Surg. Oncol., September 1, 2007; 14(9): 2470 - 2476.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
H. Dihazi, G. A. Muller, S. Lindner, M. Meyer, A. R. Asif, M. Oellerich, and F. Strutz
Characterization of Diabetic Nephropathy by Urinary Proteomic Analysis: Identification of a Processed Ubiquitin Form as a Differentially Excreted Protein in Diabetic Nephropathy Patients
Clin. Chem., September 1, 2007; 53(9): 1636 - 1645.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
S. McIlwain, D. Page, E. L. Huttlin, and M. R. Sussman
Using dynamic programming to create isotopic distribution maps from mass spectra
Bioinformatics, July 1, 2007; 23(13): i328 - i336.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
C. Matsumoto, T. Kojima, K. Ogawa, S. Kamegai, T. Oyama, Y. Shibagaki, T. Kawasaki, H. Fujinaga, K. Takahashi, H. Hikiami, et al.
A Proteomic Approach for the Diagnosis of 'Oketsu' (blood stasis), a Pathophysiologic Concept of Japanese Traditional (Kampo) Medicine
Evid. Based Complement. Altern. Med., June 15, 2007; (2007) nem049v1.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
L. R. Rodrigues, J. A. Teixeira, F. L. Schmitt, M. Paulsson, and H. Lindmark-Mansson
The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer
Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1087 - 1097.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. F. Lopez, A. Mikulskis, S. Kuzdzal, E. Golenko, E. F. Petricoin III, L. A. Liotta, W. F. Patton, G. R. Whiteley, K. Rosenblatt, P. Gurnani, et al.
A Novel, High-Throughput Workflow for Discovery and Identification of Serum Carrier Protein-Bound Peptide Biomarker Candidates in Ovarian Cancer Samples
Clin. Chem., June 1, 2007; 53(6): 1067 - 1074.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
H. H. Otu, H. Can, D. Spentzos, R. G. Nelson, R. L. Hanson, H. C. Looker, W. C. Knowler, M. Monroy, T. A. Libermann, S. A. Karumanchi, et al.
Prediction of Diabetic Nephropathy Using Urine Proteomic Profiling 10 Years Prior to Development of Nephropathy
Diabetes Care, March 1, 2007; 30(3): 638 - 643.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Aivado, D. Spentzos, U. Germing, G. Alterovitz, X.-Y. Meng, F. Grall, A. A. N. Giagounidis, G. Klement, U. Steidl, H. H. Otu, et al.
From the cover: Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease
PNAS, January 23, 2007; 104(4): 1307 - 1312.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
P. Qiu, Z. J. Wang, K. J. R. Liu, Z.-Z. Hu, and C. H. Wu
Dependence network modeling for biomarker identification
Bioinformatics, January 15, 2007; 23(2): 198 - 206.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
Y. Guo, Z. Fu, and J. E. Van Eyk
A Proteomic Primer for the Clinician
Proceedings of the ATS, January 1, 2007; 4(1): 9 - 17.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Nakagawa, S. K. Huang, S. R. Martinez, A. N. Tran, D. Elashoff, X. Ye, R. R. Turner, A. E. Giuliano, and D. S.B. Hoon
Proteomic Profiling of Primary Breast Cancer Predicts Axillary Lymph Node Metastasis
Cancer Res., December 15, 2006; 66(24): 11825 - 11830.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
F. Bertucci, D. Birnbaum, and A. Goncalves
Proteomics of Breast Cancer: Principles and Potential Clinical Applications
Mol. Cell. Proteomics, October 1, 2006; 5(10): 1772 - 1786.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
N. S. Azad, N. Rasool, C. M. Annunziata, L. Minasian, G. Whiteley, and E. C. Kohn
Proteomics in Clinical Trials and Practice: Present Uses and Future Promise
Mol. Cell. Proteomics, October 1, 2006; 5(10): 1819 - 1829.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
R. R. Drake, E. E. Schwegler, G. Malik, J. Diaz, T. Block, A. Mehta, and O. J. Semmes
Lectin Capture Strategies Combined with Mass Spectrometry for the Discovery of Serum Glycoprotein Biomarkers
Mol. Cell. Proteomics, October 1, 2006; 5(10): 1957 - 1967.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
J. Villanueva, A. J. Martorella, K. Lawlor, J. Philip, M. Fleisher, R. J. Robbins, and P. Tempst
Serum Peptidome Patterns That Distinguish Metastatic Thyroid Carcinoma from Cancer-free Controls Are Unbiased by Gender and Age
Mol. Cell. Proteomics, October 1, 2006; 5(10): 1840 - 1852.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
Z. Yang, L. E. Harris, D. E. Palmer-Toy, and W. S. Hancock
Multilectin Affinity Chromatography for Characterization of Multiple Glycoprotein Biomarker Candidates in Serum from Breast Cancer Patients
Clin. Chem., October 1, 2006; 52(10): 1897 - 1905.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
Q. C. Ru, L. A. Zhu, J. Silberman, and C. D. Shriver
Label-free Semiquantitative Peptide Feature Profiling of Human Breast Cancer and Breast Disease Sera via Two-dimensional Liquid Chromatography-Mass Spectrometry
Mol. Cell. Proteomics, June 1, 2006; 5(6): 1095 - 1104.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. Li, Z. Zhang, and D. W. Chan
Validation of Breast Cancer Biomarkers Identified by Mass Spectrometry: Some of the authors of the article cited above respond:
Clin. Chem., April 1, 2006; 52(4): 772 - 772.
[Full Text] [PDF]

Home page
 JCOHome page
R. S. Dua, C. M. Isacke, and G. P.H. Gui
The Intraductal Approach to Breast Cancer Biomarker Discovery
J. Clin. Oncol., March 1, 2006; 24(7): 1209 - 1216.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Li, J. Zhao, X. Yu, J. Lange, H. Kuerer, S. Krishnamurthy, E. Schilling, S. A. Khan, S. Sukumar, and D. W. Chan
Identification of Biomarkers for Breast Cancer in Nipple Aspiration and Ductal Lavage Fluid
Clin. Cancer Res., December 1, 2005; 11(23): 8312 - 8320.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. Li, R. Orlandi, C. N. White, J. Rosenzweig, J. Zhao, E. Seregni, D. Morelli, Y. Yu, X.-Y. Meng, Z. Zhang, et al.
Independent Validation of Candidate Breast Cancer Serum Biomarkers Identified by Mass Spectrometry
Clin. Chem., December 1, 2005; 51(12): 2229 - 2235.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A.-J. Cheng, L.-C. Chen, K.-Y. Chien, Y.-J. Chen, J. T.-C. Chang, H.-M. Wang, C.-T. Liao, and I-H. Chen
Oral Cancer Plasma Tumor Marker Identified with Bead-Based Affinity-Fractionated Proteomic Technology
Clin. Chem., December 1, 2005; 51(12): 2236 - 2244.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
H. W. Ressom, R. S. Varghese, M. Abdel-Hamid, S. A.-L. Eissa, D. Saha, L. Goldman, E. F. Petricoin, T. P. Conrads, T. D. Veenstra, C. A. Loffredo, et al.
Analysis of mass spectral serum profiles for biomarker selection
Bioinformatics, November 1, 2005; 21(21): 4039 - 4045.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. E. Banks, A. J. Stanley, D. A. Cairns, J. H. Barrett, P. Clarke, D. Thompson, and P. J. Selby
Influences of Blood Sample Processing on Low-Molecular-Weight Proteome Identified by Surface-Enhanced Laser Desorption/Ionization Mass Spectrometry
Clin. Chem., September 1, 2005; 51(9): 1637 - 1649.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. J. Robbins, J. Villanueva, and P. Tempst
Distilling Cancer Biomarkers From the Serum Peptidome: High Technology Reading of Tea Leaves or an Insight to Clinical Systems Biology?
J. Clin. Oncol., August 1, 2005; 23(22): 4835 - 4837.
[Full Text] [PDF]

Home page
 JCOHome page
S. Mian, S. Ugurel, E. Parkinson, I. Schlenzka, I. Dryden, L. Lancashire, G. Ball, C. Creaser, R. Rees, and D. Schadendorf
Serum Proteomic Fingerprinting Discriminates Between Clinical Stages and Predicts Disease Progression in Melanoma Patients
J. Clin. Oncol., August 1, 2005; 23(22): 5088 - 5093.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Karsan, B. J. Eigl, S. Flibotte, K. Gelmon, P. Switzer, P. Hassell, D. Harrison, J. Law, M. Hayes, M. Stillwell, et al.
Analytical and Preanalytical Biases in Serum Proteomic Pattern Analysis for Breast Cancer Diagnosis
Clin. Chem., August 1, 2005; 51(8): 1525 - 1528.
[Full Text] [PDF]

Home page
 BioinformaticsHome page
N. Jeffries
Algorithms for alignment of mass spectrometry proteomic data
Bioinformatics, July 15, 2005; 21(14): 3066 - 3073.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. Kim, P. Sun, Y.-W. Lam, P. Troncoso, A. L. Sabichi, R. J. Babaian, L. L. Pisters, C. A. Pettaway, C. G. Wood, S. M. Lippman, et al.
Changes in Serum Proteomic Patterns by Presurgical {alpha}-Tocopherol and L-Selenomethionine Supplementation in Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1697 - 1702.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
F M Brouwers, E F Petricoin III, L Ksinantova, J Breza, V Rajapakse, S Ross, D Johann, M Mannelli, B L Shulkin, R Kvetnansky, et al.
Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma
Endocr. Relat. Cancer, June 1, 2005; 12(2): 263 - 272.
[Abstract] [Full Text] [PDF]

Home page
 Adv. Dent. Res.Home page
C. Streckfus and L. Bigler
The Use of Soluble, Salivary c-erbB-2 for the Detection and Post-operative Follow-up of Breast Cancer in Women: The Results of a Five-year Translational Research Study
Adv. Dent. Res., June 1, 2005; 18(1): 17 - 24.
[Full Text] [PDF]

Home page
 BioinformaticsHome page
H. Bensmail, J. Golek, M. M. Moody, J. O. Semmes, and A. Haoudi
A novel approach for clustering proteomics data using Bayesian fast Fourier transform
Bioinformatics, May 15, 2005; 21(10): 2210 - 2224.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. Meyerson and D. Carbone
Genomic and Proteomic Profiling of Lung Cancers: Lung Cancer Classification in the Age of Targeted Therapy
J. Clin. Oncol., May 10, 2005; 23(14): 3219 - 3226.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
L. Le, K. Chi, S. Tyldesley, S. Flibotte, D. L. Diamond, M. A. Kuzyk, and M. D. Sadar
Identification of Serum Amyloid A as a Biomarker to Distinguish Prostate Cancer Patients with Bone Lesions
Clin. Chem., April 1, 2005; 51(4): 695 - 707.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
F. H. Grus, V. N. Podust, K. Bruns, K. Lackner, S. Fu, E. A. Dalmasso, A. Wirthlin, and N. Pfeiffer
SELDI-TOF-MS ProteinChip Array Profiling of Tears from Patients with Dry Eye
Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 863 - 876.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
L. A. Liotta, M. Lowenthal, A. Mehta, T. P. Conrads, T. D. Veenstra, D. A. Fishman, and E. F. Petricoin III
Importance of Communication Between Producers and Consumers of Publicly Available Experimental Data
J Natl Cancer Inst, February 16, 2005; 97(4): 310 - 314.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. Malik, M. D. Ward, S. K. Gupta, M. W. Trosset, W. E. Grizzle, B.-L. Adam, J. I. Diaz, and O. J. Semmes
Serum Levels of an Isoform of Apolipoprotein A-II as a Potential Marker for Prostate Cancer
Clin. Cancer Res., February 1, 2005; 11(3): 1073 - 1085.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. M. Koomen, L. N. Shih, K. R. Coombes, D. Li, L.-c. Xiao, I. J. Fidler, J. L. Abbruzzese, and R. Kobayashi
Plasma Protein Profiling for Diagnosis of Pancreatic Cancer Reveals the Presence of Host Response Proteins
Clin. Cancer Res., February 1, 2005; 11(3): 1110 - 1118.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
E. M. Posadas, F. Simpkins, L. A. Liotta, C. MacDonald, and E. C. Kohn
Proteomic analysis for the early detection and rational treatment of cancer--realistic hope?
Ann. Onc., January 1, 2005; 16(1): 16 - 22.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
O. J. Semmes, Z. Feng, B.-L. Adam, L. L. Banez, W. L. Bigbee, D. Campos, L. H. Cazares, D. W. Chan, W. E. Grizzle, E. Izbicka, et al.
Evaluation of Serum Protein Profiling by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry for the Detection of Prostate Cancer: I. Assessment of Platform Reproducibility
Clin. Chem., January 1, 2005; 51(1): 102 - 112.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y.-d. Chen, S. Zheng, J.-k. Yu, and X. Hu
Artificial Neural Networks Analysis of Surface-Enhanced Laser Desorption/Ionization Mass Spectra of Serum Protein Pattern Distinguishes Colorectal Cancer from Healthy Population
Clin. Cancer Res., December 15, 2004; 10(24): 8380 - 8385.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. Rej
Clinical Chemistry through Clinical Chemistry: A Journal Timeline
Clin. Chem., December 1, 2004; 50(12): 2415 - 2458.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
E. O'Riordan, T. N. Orlova, J. Mei J, K. Butt, P. M. Chander, S. Rahman, M. Mya, R. Hu, J. Momin, E. W. Eng, et al.
Bioinformatic Analysis of the Urine Proteome of Acute Allograft Rejection
J. Am. Soc. Nephrol., December 1, 2004; 15(12): 3240 - 3248.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
S. Becker, L. H. Cazares, P. Watson, H. Lynch, O. J. Semmes, R. R. Drake, and C. Laronga
Surfaced-Enhanced Laser Desorption/Ionization Time-of-Flight (SELDI-TOF) Differentiation of Serum Protein Profiles of BRCA-1 and Sporadic Breast Cancer
Ann. Surg. Oncol., October 1, 2004; 11(10): 907 - 914.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Zhang, R. C. Bast Jr., Y. Yu, J. Li, L. J. Sokoll, A. J. Rai, J. M. Rosenzweig, B. Cameron, Y. Y. Wang, X.-Y. Meng, et al.
Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer
Cancer Res., August 15, 2004; 64(16): 5882 - 5890.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Vlahou, A. Giannopoulos, B. W. Gregory, T. Manousakas, F. I. Kondylis, L. L. Wilson, P. F. Schellhammer, G. L. Wright Jr, and O. J. Semmes
Protein Profiling in Urine for the Diagnosis of Bladder Cancer
Clin. Chem., August 1, 2004; 50(8): 1438 - 1441.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. G. Soltys, Q.-T. Le, G. Shi, R. Tibshirani, A. J. Giaccia, and A. C. Koong
The Use of Plasma Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Proteomic Patterns for Detection of Head and Neck Squamous Cell Cancers
Clin. Cancer Res., July 15, 2004; 10(14): 4806 - 4812.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y.-P. Lim, C. Y. Wong, L. L. Ooi, B. J. Druker, and R. J. Epstein
Selective Tyrosine Hyperphosphorylation of Cytoskeletal and Stress Proteins in Primary Human Breast Cancers: Implications for Adjuvant Use of Kinase-Inhibitory Drugs
Clin. Cancer Res., June 15, 2004; 10(12): 3980 - 3987.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Xiao, B. T. Luke, G. Izmirlian, A. Umar, P. M. Lynch, R. K. S. Phillips, S. Patterson, T. P. Conrads, T. D. Veenstra, P. Greenwald, et al.
Serum Proteomic Profiles Suggest Celecoxib-Modulated Targets and Response Predictors
Cancer Res., April 15, 2004; 64(8): 2904 - 2909.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
I. J. Jacobs and U. Menon
Progress and Challenges in Screening for Early Detection of Ovarian Cancer
Mol. Cell. Proteomics, April 1, 2004; 3(4): 355 - 366.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
E. P. Diamandis
Analysis of Serum Proteomic Patterns for Early Cancer Diagnosis: Drawing Attention to Potential Problems
J Natl Cancer Inst, March 3, 2004; 96(5): 353 - 356.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. T. Wadsworth, K. D. Somers, L. H. Cazares, G. Malik, B.-L. Adam, B. C. Stack Jr., G. L. Wright Jr., and O. J. Semmes
Serum Protein Profiles to Identify Head and Neck Cancer
Clin. Cancer Res., March 1, 2004; 10(5): 1625 - 1632.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
B. Lumbreras-Lacarra, J. M. Ramos-Rincon, and I. Hernandez-Aguado
Methodology in Diagnostic Laboratory Test Research in Clinical Chemistry and Clinical Chemistry and Laboratory Medicine
Clin. Chem., March 1, 2004; 50(3): 530 - 536.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. H. Geho, E. F. Petricoin, and L. A. Liotta
Blasting into the Microworld of Tissue Proteomics: A New Window on Cancer: Commentary re S. A. Schwartz et al., Protein Profiling in Brain Tumors Using Mass Spectrometry: Feasibility of a New